[DOI] [PubMed] [Google Scholar] 43.Varzi HN, Esmailzadeh S, Morovvati H, Avizeh R, Shahriari A, Givi ME
In a randomized controlled trial, an extract from gynostemma modestly reduced body weight and fat mass in obese subjects (Park, Huh 2014)
External resources Efficacy and safety of retatrutide: systematic review and meta-analysis (PMC) Triple hormone receptor agonist retatrutide for obesity: Phase 2 trial (NEJM) Tesamorelin clinical pharmacology and safety (NCBI LiverTox) Safety and metabolic effects of tesamorelin in type 2 diabetes (PMC) Tesamorelin prescribing information and side effects (Mayo Clinic) Retatrutide for metabolic dysfunction-associated steatotic liver disease (Nature Medicine) For researchers serious about optimizing their peptide protocols, SeekPeptides offers the most comprehensive resource available, with evidence-based guides, proven protocols, and a community of thousands who have navigated these exact questions
GLP-1RAs have been shown to improve liver health in patients with NAFLD and type 2 diabetes, as well as non-alcoholic steatohepatitis (NASH) [13, 29]
Vomiting, diarrhea, and constipation are also frequent
